PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))

Term ID

CHEBI:89117

Synonyms

1-(8Z,11Z,14Z-Eicosatrienoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-Homo-g-linolenoyl-2-linoleoyl-sn-glycero-3-phosphoinositol
1-Homo-gamma-linolenoyl-2-linoleoyl-sn-glycero-3-phosphoinositol
[(2R)-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(20:3/18:2)
Phosphatidylinositol(20:3n6/18:2n6)
Phosphatidylinositol(20:3w6/18:2w6)
Phosphatidylinositol(38:5)
PI(20:3/18:2)
PI(20:3n6/18:2n6)
PI(20:3w6/18:2w6)
PI(38:5)
PIno(20:3/18:2)
PIno(20:3n6/18:2n6)
PIno(20:3w6/18:2w6)
PIno(38:5)

(all 16)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))

Phenotype where environments contain PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))

Phenotype modified by environments containing PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))

Phenotype affecting PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))

Human Disease Model